Compare LUV & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LUV | RMD |
|---|---|---|
| Founded | 1967 | 1989 |
| Country | United States | United States |
| Employees | N/A | 10600 |
| Industry | Air Freight/Delivery Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.9B | 28.4B |
| IPO Year | 1995 | N/A |
| Metric | LUV | RMD |
|---|---|---|
| Price | $50.03 | $209.22 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 18 | 10 |
| Target Price | $45.37 | ★ $292.56 |
| AVG Volume (30 Days) | ★ 6.7M | 1.3M |
| Earning Date | 04-22-2026 | 04-30-2026 |
| Dividend Yield | ★ 1.93% | 1.13% |
| EPS Growth | ★ 3.95 | N/A |
| EPS | ★ 0.45 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $16.57 | $10.60 |
| Revenue Next Year | $3.61 | $7.41 |
| P/E Ratio | $111.67 | ★ $25.61 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $28.98 | $180.27 |
| 52 Week High | $55.11 | $293.81 |
| Indicator | LUV | RMD |
|---|---|---|
| Relative Strength Index (RSI) | 65.14 | 62.23 |
| Support Level | $49.80 | $198.63 |
| Resistance Level | $55.11 | $211.74 |
| Average True Range (ATR) | 1.74 | 4.86 |
| MACD | 0.17 | 2.25 |
| Stochastic Oscillator | 68.46 | 99.80 |
Southwest Airlines is the largest domestic air carrier in the United States by passengers boarded. Southwest operates nearly 800 aircraft in an all-Boeing 737 fleet. Despite offering some longer routes and a few perks for business travelers, the airline predominantly specializes in short-haul, leisure flights operated with a simple cabin configuration in a point-to-point network. In early 2026, Southwest modified its cabins to offer some rows with extra legroom, its ticketing process and merchandising to offer assigned seats, and more fare categories to include a basic economy class that appears for the first time in travel aggregators' search results and more directly competes with other airlines' offerings.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks, and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with aging populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two-thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan, and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor, and payer in the out-of-hospital setting.